腹腔热化疗对防治胃肠道癌术后复发的临床意义  

Clinical significance for the control of the peritoneal recurrence in gastrointestinal cancer by continuous hyperthermic peritoneal perfusion.

作　　者：谭广[1] 吴功侃[1] 李琪 谭毓铨[2] 

机构地区：[1]大连医科大学附属第一医院,116011 [2]白求恩医科大学第一临床学院,长春130021

出　　处：《中国实用外科杂志》2000年第3期165-166,共2页Chinese Journal of Practical Surgery

摘　　要：目的　探讨进展期胃肠道癌手术切除后腹腔复发转移的防治方法。方法　对 5 3例进展期胃肠道癌病人分组行围手术期持续腹腔温热化疗 ,并对其化疗术后 1、2、3年生存率对照研究。结果　 2 7例病人实施腹腔化疗后 1、2、3年生存期分别为 88 46 % ,80 76 % ,6 9 2 3 %明显高于对照组的 84 6 1% ,6 1 5 %及 46 2 % ,且并发症与副作用无差异。结论　腹腔温热化疗对进展期胃肠道癌术后复发有良好的防治作用。Objective To study the treatment for the peritoneal recurrence of the advanced gastrointestinal cancer after radical resection.Methods 53 patients were divided into treated and control group.The 1,2 and 3 year survival rates of each group were analyzed.Results After CHPP 1 6 times for 27 patients in treated group,the 1,2 and 3 year survival rates were 88 4%,80 76% and 69 23% respectively,higher than control group which were 84 61%,61 5% and 46 2% respectively.Conclusion CHPP is an effective way to control the recurrence of advanced gastrointestinal cancer after operation.

关 键 词：腹腔热化疗 胃肠道癌 复发 防治 CHPP 

分 类 号：R735.05[医药卫生—肿瘤]